CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In millions)
Years ended
September 27,
September 28,
September 30,
Net income
112,010
93,736
96,995
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax
Change in unrealized gains/losses on derivative instruments, net of tax:
Change in fair value of derivative instruments
Adjustment for net (gains)/losses realized and included in net income
1,337
1,717
Total change in unrealized gains/losses on derivative instruments
2,169
1,394
Change in unrealized gains/losses on marketable debt securities, net of tax:
Change in fair value of marketable debt securities
5,850
1,563
Adjustment for net (gains)/losses realized and included in net income
Total change in unrealized gains/losses on marketable debt securities
1,231
6,054
1,816
Total other comprehensive income/(loss)
1,601
4,280
Total comprehensive income
113,611
98,016
96,652
See accompanying Notes to Consolidated Financial Statements.
Apple Inc. | 2025 Form 10-K | 30
Apple Inc.

Question: What was Apple Inc.'s net income in fiscal year 2025?

what was apple inc.'s net income in fiscal year 2025?

what was net income in fiscal year 2025?

(in millions) years ended september 27 september 28 september 30 net income 112010 93736 96995 other comprehensive income/(loss): change in foreign currency translation net of tax change in unrealized gains/losses on derivative instruments net of tax: change in fair value of derivative instruments adjustment for net (gains)/losses realized and included in net income 1337 1717 total change in unrealized gains/losses on derivative instruments 2169 1394 change in unrealized gains/losses on marketable debt securities net of tax: change in fair value of marketable debt securities 5850 1563 adjustment for net (gains)/losses realized and included in net income total change in unrealized gains/losses on marketable debt securities 1231 6054 1816 total other comprehensive income/(loss) 1601 4280 total comprehensive income 113611 98016 96652 see accompanying notes to consolidated financial statements. apple inc. | 2025 form 10-k | 30 apple inc.


(In millions)
Years ended
September 27,
September 28,
September 30,
Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances
29,943
30,737
24,977
Operating activities:
Net income
112,010
93,736
96,995
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
11,698
11,445
11,519
Share-based compensation expense
12,863
11,688
10,833
Other
2,266
2,227
Changes in operating assets and liabilities:
Accounts receivable, net
6,682
3,788
1,688
Vendor non-trade receivables
1,356
1,271
Inventories
1,400
1,046
1,618
Other current and non-current assets
9,197
11,731
5,684
Accounts payable
6,020
1,889
Other current and non-current liabilities
11,076
15,552
3,031
Cash generated by operating activities
111,482
118,254
110,543
Investing activities:
Purchases of marketable securities
24,407
48,656
29,513
Proceeds from maturities of marketable securities
40,907
51,211
39,686
Proceeds from sales of marketable securities
12,890
11,135
5,828
Payments for acquisition of property, plant and equipment
12,715
9,447
10,959
Other
1,480
1,308
1,337
Cash generated by investing activities
15,195
2,935
3,705
Financing activities:
Payments for taxes related to net share settlement of equity awards
5,960
5,441
5,431
Payments for dividends and dividend equivalents
15,421
15,234
15,025
Repurchases of common stock
90,711
94,949
77,550
Proceeds from issuance of term debt, net
4,481
5,228
Repayments of term debt
10,932
9,958
11,151
Proceeds from/(Repayments of) commercial paper, net
2,032
3,960
3,978
Other
Cash used in financing activities
120,686
121,983
108,488
Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents
5,991
5,760
Cash, cash equivalents, and restricted cash and cash equivalents, ending balances
35,934
29,943
30,737
Supplemental cash flow disclosure:
Cash paid for income taxes, net
43,369
26,102
18,679
See accompanying Notes to Consolidated Financial Statements.
Apple Inc. | 2025 Form 10-K | 33
Apple Inc.

Question: What was Apple Inc.'s operating cash flow in fiscal year 2025?

net cash provided by used in operating activities

what was apple inc.'s operating cash flow in fiscal year 2025?

what was operating cash flow in fiscal year 2025?

(in millions) years ended september 27 september 28 september 30 cash cash equivalents and restricted cash and cash equivalents beginning balances 29943 30737 24977 operating activities: net income 112010 93736 96995 adjustments to reconcile net income to cash generated by operating activities: depreciation and amortization 11698 11445 11519 share-based compensation expense 12863 11688 10833 other 2266 2227 changes in operating assets and liabilities: accounts receivable net 6682 3788 1688 vendor non-trade receivables 1356 1271 inventories 1400 1046 1618 other current and non-current assets 9197 11731 5684 accounts payable 6020 1889 other current and non-current liabilities 11076 15552 3031 cash generated by operating activities 111482 118254 110543 investing activities: purchases of marketable securities 24407 48656 29513 proceeds from maturities of marketable securities 40907 51211 39686 proceeds from sales of marketable securities 12890 11135 5828 payments for acquisition of property plant and equipment 12715 9447 10959 other 1480 1308 1337 cash generated by investing activities 15195 2935 3705 financing activities: payments for taxes related to net share settlement of equity awards 5960 5441 5431 payments for dividends and dividend equivalents 15421 15234 15025 repurchases of common stock 90711 94949 77550 proceeds from issuance of term debt net 4481 5228 repayments of term debt 10932 9958 11151 proceeds from/(repayments of) commercial paper net 2032 3960 3978 other cash used in financing activities 120686 121983 108488 increase/(decrease) in cash cash equivalents and restricted cash and cash equivalents 5991 5760 cash cash equivalents and restricted cash and cash equivalents ending balances 35934 29943 30737 supplemental cash flow disclosure: cash paid for income taxes net 43369 26102 18679 see accompanying notes to consolidated financial statements. apple inc. | 2025 form 10-k | 33 apple inc.


(In millions, except number of shares, which are reflected in thousands, and per-share amounts)
Years ended
September 27,
September 28,
September 30,
Net sales:
Products
307,003
294,866
298,085
Services
109,158
96,169
85,200
Total net sales
416,161
391,035
383,285
Cost of sales:
Products
194,116
185,233
189,282
Services
26,844
25,119
24,855
Total cost of sales
220,960
210,352
214,137
Gross margin
195,201
180,683
169,148
Operating expenses:
Research and development
34,550
31,370
29,915
Selling, general and administrative
27,601
26,097
24,932
Total operating expenses
62,151
57,467
54,847
Operating income
133,050
123,216
114,301
Other income/(expense), net
Income before provision for income taxes
132,729
123,485
113,736
Provision for income taxes
20,719
29,749
16,741
Net income
112,010
93,736
96,995
Earnings per share:
Basic
7.49
6.11
6.16
Diluted
7.46
6.08
6.13
Shares used in computing earnings per share:
Basic
14,948,500
15,343,783
15,744,231
Diluted
15,004,697
15,408,095
15,812,547
See accompanying Notes to Consolidated Financial Statements.
Apple Inc. | 2025 Form 10-K | 29
Apple Inc.

Question: What was Apple Inc.'s revenue in fiscal year 2025?

revenue from contract with customer excluding assessed tax

what was apple inc.'s revenue in fiscal year 2025?

(in millions except number of shares which are reflected in thousands and per-share amounts) years ended september 27 september 28 september 30 net sales: products 307003 294866 298085 services 109158 96169 85200 total net sales 416161 391035 383285 cost of sales: products 194116 185233 189282 services 26844 25119 24855 total cost of sales 220960 210352 214137 gross margin 195201 180683 169148 operating expenses: research and development 34550 31370 29915 selling general and administrative 27601 26097 24932 total operating expenses 62151 57467 54847 operating income 133050 123216 114301 other income/(expense) net income before provision for income taxes 132729 123485 113736 provision for income taxes 20719 29749 16741 net income 112010 93736 96995 earnings per share: basic 7.49 6.11 6.16 diluted 7.46 6.08 6.13 shares used in computing earnings per share: basic 14948500 15343783 15744231 diluted 15004697 15408095 15812547 see accompanying notes to consolidated financial statements. apple inc. | 2025 form 10-k | 29 apple inc.


(In millions, except number of shares, which are reflected in thousands, and par value)
September 27,
September 28,
ASSETS:
Current assets:
Cash and cash equivalents
35,934
29,943
Marketable securities
18,763
35,228
Accounts receivable, net
39,777
33,410
Vendor non-trade receivables
33,180
32,833
Inventories
5,718
7,286
Other current assets
14,585
14,287
Total current assets
147,957
152,987
Non-current assets:
Marketable securities
77,723
91,479
Property, plant and equipment, net
49,834
45,680
Other non-current assets
83,727
74,834
Total non-current assets
211,284
211,993
Total assets
359,241
364,980
LIABILITIES AND SHAREHOLDERS’ EQUITY:
Current liabilities:
Accounts payable
69,860
68,960
Other current liabilities
66,387
78,304
Deferred revenue
9,055
8,249
Commercial paper
7,979
9,967
Term debt
12,350
10,912
Total current liabilities
165,631
176,392
Non-current liabilities:
Term debt
78,328
85,750
Other non-current liabilities
41,549
45,888
Total non-current liabilities
119,877
131,638
Total liabilities
285,508
308,030
Commitments and contingencies
Shareholders’ equity:
Common stock and additional paid-in capital, $
0.00001
par value:
50,400,000
shares authorized;
14,773,260
and
15,116,786
shares issued and outstanding, respectively
93,568
83,276
Accumulated deficit
14,264
19,154
Accumulated other comprehensive loss
5,571
7,172
Total shareholders’ equity
73,733
56,950
Total liabilities and shareholders’ equity
359,241
364,980
See accompanying Notes to Consolidated Financial Statements.
Apple Inc. | 2025 Form 10-K | 31
Apple Inc.

Question: What was Apple Inc.'s total assets in fiscal year 2025?

what was apple inc.'s total assets in fiscal year 2025?

what was total assets in fiscal year 2025?

(in millions except number of shares which are reflected in thousands and par value) september 27 september 28 assets: current assets: cash and cash equivalents 35934 29943 marketable securities 18763 35228 accounts receivable net 39777 33410 vendor non-trade receivables 33180 32833 inventories 5718 7286 other current assets 14585 14287 total current assets 147957 152987 non-current assets: marketable securities 77723 91479 property plant and equipment net 49834 45680 other non-current assets 83727 74834 total non-current assets 211284 211993 total assets 359241 364980 liabilities and shareholders' equity: current liabilities: accounts payable 69860 68960 other current liabilities 66387 78304 deferred revenue 9055 8249 commercial paper 7979 9967 term debt 12350 10912 total current liabilities 165631 176392 non-current liabilities: term debt 78328 85750 other non-current liabilities 41549 45888 total non-current liabilities 119877 131638 total liabilities 285508 308030 commitments and contingencies shareholders' equity: common stock and additional paid-in capital 0.00001 par value: 50400000 shares authorized; 14773260 and 15116786 shares issued and outstanding respectively 93568 83276 accumulated deficit 14264 19154 accumulated other comprehensive loss 5571 7172 total shareholders' equity 73733 56950 total liabilities and shareholders' equity 359241 364980 see accompanying notes to consolidated financial statements. apple inc. | 2025 form 10-k | 31 apple inc.


Question: What was Apple Inc.'s gross margin in fiscal year 2025?

what was apple inc.'s gross margin in fiscal year 2025?


Question: What was Apple Inc.'s net margin in fiscal year 2025?

what was apple inc.'s net margin in fiscal year 2025?


Question: What was Apple Inc.'s operating cash flow margin in fiscal year 2025?

what was apple inc.'s operating cash flow margin in fiscal year 2025?


Question: By what percentage did Apple Inc.'s net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did apple inc.'s net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did net income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did Apple Inc.'s operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did apple inc.'s operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did operating income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did Apple Inc.'s revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did apple inc.'s revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did revenue change from fiscal year 2024 to fiscal year 2025?


CASH FLOWS S
TATEMENTS
(In millions)
Year Ended June 30,
Operations
Net income
101,832
88,136
72,361
Adjustments to reconcile net income to net cash from operations:
Depreciation, amortization, and other
34,153
22,287
13,861
Stock-based compensation expense
11,974
10,734
9,611
Net recognized losses on investments and derivatives
Deferred income taxes
7,056
4,738
6,059
Changes in operating assets and liabilities:
Accounts receivable
10,581
7,191
4,087
Inventories
1,284
1,242
Other current assets
3,044
1,648
1,991
Other long-term assets
2,950
6,817
2,833
Accounts payable
3,545
2,721
Unearned revenue
5,438
5,348
5,535
Income taxes
1,687
Other current liabilities
5,922
4,867
2,272
Other long-term liabilities
Net cash from operations
136,162
118,548
87,582
Financing
Proceeds from issuance (repayments) of debt, maturities of 90 days or less, net
5,746
5,250
Proceeds from issuance of debt
24,395
Repayments of debt
3,216
29,070
2,750
Common stock issued
2,056
2,002
1,866
Common stock repurchased
18,420
17,254
22,245
Common stock cash dividends paid
24,082
21,771
19,800
Other, net
2,291
1,309
1,006
Net cash used in financing
51,699
37,757
43,935
Investing
Additions to property and equipment
64,551
44,477
28,107
Acquisition of companies, net of cash acquired and divestitures, and purchases of intangible and other assets
5,978
69,132
1,670
Purchases of investments
29,775
17,732
37,651
Maturities of investments
16,079
24,775
33,510
Sales of investments
9,309
10,894
14,354
Other, net
2,317
1,298
3,116
Net cash used in investing
72,599
96,970
22,680
Effect of foreign exchange rates on cash and cash equivalents
Net change in cash and cash equivalents
11,927
16,389
20,773
Cash and cash equivalents, beginning of period
18,315
34,704
13,931
Cash and cash equivalents, end of period
30,242
18,315
34,704
Refer to accompanying notes.

Question: What was Microsoft Corporation's net income in fiscal year 2025?

what was microsoft corporation's net income in fiscal year 2025?

what was net income in fiscal year 2025?

cash flows s tatements (in millions) year ended june 30 operations net income 101832 88136 72361 adjustments to reconcile net income to net cash from operations: depreciation amortization and other 34153 22287 13861 stock-based compensation expense 11974 10734 9611 net recognized losses on investments and derivatives deferred income taxes 7056 4738 6059 changes in operating assets and liabilities: accounts receivable 10581 7191 4087 inventories 1284 1242 other current assets 3044 1648 1991 other long-term assets 2950 6817 2833 accounts payable 3545 2721 unearned revenue 5438 5348 5535 income taxes 1687 other current liabilities 5922 4867 2272 other long-term liabilities net cash from operations 136162 118548 87582 financing proceeds from issuance (repayments) of debt maturities of 90 days or less net 5746 5250 proceeds from issuance of debt 24395 repayments of debt 3216 29070 2750 common stock issued 2056 2002 1866 common stock repurchased 18420 17254 22245 common stock cash dividends paid 24082 21771 19800 other net 2291 1309 1006 net cash used in financing 51699 37757 43935 investing additions to property and equipment 64551 44477 28107 acquisition of companies net of cash acquired and divestitures and purchases of intangible and other assets 5978 69132 1670 purchases of investments 29775 17732 37651 maturities of investments 16079 24775 33510 sales of investments 9309 10894 14354 other net 2317 1298 3116 net cash used in investing 72599 96970 22680 effect of foreign exchange rates on cash and cash equivalents net change in cash and cash equivalents 11927 16389 20773 cash and cash equivalents beginning of period 18315 34704 13931 cash and cash equivalents end of period 30242 18315 34704 refer to accompanying notes.


MENTS AND SUPPLEMENTARY DATA
INC
OME STATEMENTS
(In millions, except per share amounts)
Year Ended June 30,
Revenue:
Product
63,946
64,773
64,699
Service and other
217,778
180,349
147,216
Total revenue
281,724
245,122
211,915
Cost of revenue:
Product
13,501
15,272
17,804
Service and other
74,330
58,842
48,059
Total cost of revenue
87,831
74,114
65,863
Gross margin
193,893
171,008
146,052
Research and development
32,488
29,510
27,195
Sales and marketing
25,654
24,456
22,759
General and administrative
7,223
7,609
7,575
Operating income
128,528
109,433
88,523
Other income (expense), net
4,901
1,646
Income before income taxes
123,627
107,787
89,311
Provision for income taxes
21,795
19,651
16,950
Net income
101,832
88,136
72,361
Earnings per share:
Basic
13.70
11.86
9.72
Diluted
13.64
11.80
9.68
Weighted average shares outstanding:
Basic
7,433
7,431
7,446
Diluted
7,465
7,469
7,472
Refer to accompanying notes.

Question: What was Microsoft Corporation's revenue in fiscal year 2025?

revenue from contract with customer excluding assessed tax

what was microsoft corporation's revenue in fiscal year 2025?

ments and supplementary data inc ome statements (in millions except per share amounts) year ended june 30 revenue: product 63946 64773 64699 service and other 217778 180349 147216 total revenue 281724 245122 211915 cost of revenue: product 13501 15272 17804 service and other 74330 58842 48059 total cost of revenue 87831 74114 65863 gross margin 193893 171008 146052 research and development 32488 29510 27195 sales and marketing 25654 24456 22759 general and administrative 7223 7609 7575 operating income 128528 109433 88523 other income (expense) net 4901 1646 income before income taxes 123627 107787 89311 provision for income taxes 21795 19651 16950 net income 101832 88136 72361 earnings per share: basic 13.70 11.86 9.72 diluted 13.64 11.80 9.68 weighted average shares outstanding: basic 7433 7431 7446 diluted 7465 7469 7472 refer to accompanying notes.


BALANCE
SHEETS
(In millions)
June 30,
Assets
Current assets:
Cash and cash equivalents
30,242
18,315
Short-term investments
64,323
57,228
Total cash, cash equivalents, and short-term investments
94,565
75,543
Accounts receivable, net of allowance for doubtful accounts of
and $
69,905
56,924
Inventories
1,246
Other current assets
25,723
26,021
Total current assets
191,131
159,734
Property and equipment, net of accumulated depreciation of
93,653
and $
76,421
204,966
135,591
Operating lease right-of-use assets
24,823
18,961
Equity and other investments
15,405
14,600
Goodwill
119,509
119,220
Intangible assets, net
22,604
27,597
Other long-term assets
40,565
36,460
Total assets
619,003
512,163
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
27,724
21,996
Short-term debt
6,693
Current portion of long-term debt
2,999
2,249
Accrued compensation
13,709
12,564
Short-term income taxes
7,211
5,017
Short-term unearned revenue
64,555
57,582
Other current liabilities
25,020
19,185
Total current liabilities
141,218
125,286
Long-term debt
40,152
42,688
Long-term income taxes
25,986
27,931
Long-term unearned revenue
2,710
2,602
Deferred income taxes
2,835
2,618
Operating lease liabilities
17,437
15,497
Other long-term liabilities
45,186
27,064
Total liabilities
275,524
243,686
Commitments and contingencies
Stockholders’ equity:
Common stock and paid-in capital – shares authorized
24,000
; outstanding
7,434
and
7,434
109,095
100,923
Retained earnings
237,731
173,144
Accumulated other comprehensive loss
3,347
5,590
Total stockholders’ equity
343,479
268,477
Total liabilities and stockholders’ equity
619,003
512,163
Refer to accompanying notes.

Question: What was Microsoft Corporation's total assets in fiscal year 2025?

what was microsoft corporation's total assets in fiscal year 2025?

what was total assets in fiscal year 2025?

balance sheets (in millions) june 30 assets current assets: cash and cash equivalents 30242 18315 short-term investments 64323 57228 total cash cash equivalents and short-term investments 94565 75543 accounts receivable net of allowance for doubtful accounts of and 69905 56924 inventories 1246 other current assets 25723 26021 total current assets 191131 159734 property and equipment net of accumulated depreciation of 93653 and 76421 204966 135591 operating lease right-of-use assets 24823 18961 equity and other investments 15405 14600 goodwill 119509 119220 intangible assets net 22604 27597 other long-term assets 40565 36460 total assets 619003 512163 liabilities and stockholders' equity current liabilities: accounts payable 27724 21996 short-term debt 6693 current portion of long-term debt 2999 2249 accrued compensation 13709 12564 short-term income taxes 7211 5017 short-term unearned revenue 64555 57582 other current liabilities 25020 19185 total current liabilities 141218 125286 long-term debt 40152 42688 long-term income taxes 25986 27931 long-term unearned revenue 2710 2602 deferred income taxes 2835 2618 operating lease liabilities 17437 15497 other long-term liabilities 45186 27064 total liabilities 275524 243686 commitments and contingencies stockholders' equity: common stock and paid-in capital – shares authorized 24000 ; outstanding 7434 and 7434 109095 100923 retained earnings 237731 173144 accumulated other comprehensive loss 3347 5590 total stockholders' equity 343479 268477 total liabilities and stockholders' equity 619003 512163 refer to accompanying notes.


Question: What was Microsoft Corporation's gross margin in fiscal year 2025?

what was microsoft corporation's gross margin in fiscal year 2025?


Question: What was Microsoft Corporation's net margin in fiscal year 2025?

what was microsoft corporation's net margin in fiscal year 2025?


Question: What was Microsoft Corporation's operating cash flow margin in fiscal year 2025?

what was microsoft corporation's operating cash flow margin in fiscal year 2025?


Question: By what percentage did Microsoft Corporation's net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did microsoft corporation's net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did net income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did Microsoft Corporation's operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did microsoft corporation's operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did operating income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did Microsoft Corporation's revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did microsoft corporation's revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did revenue change from fiscal year 2024 to fiscal year 2025?


(In millions except per share data)
Year Ended December 31,
Net Operating Revenues
47,941
47,061
45,754
Cost of goods sold
18,397
18,324
18,520
Gross Profit
29,544
28,737
27,234
Selling, general and administrative expenses
14,521
14,582
13,972
Other operating charges
1,261
4,163
1,951
Operating Income
13,762
9,992
11,311
Interest income
Interest expense
1,654
1,656
1,527
Equity income (loss) — net
2,031
1,770
1,691
Other income (loss) — net
1,073
1,992
Income Before Income Taxes
15,998
13,086
12,952
Income taxes
2,861
2,437
2,249
Consolidated Net Income
13,137
10,649
10,703
Less: Net income (loss) attributable to noncontrolling interests
Net Income Attributable to Shareowners of The Coca-Cola Company
13,107
10,631
10,714
Basic Net Income Per Share
3.05
2.47
2.48
Diluted Net Income Per Share
3.04
2.46
2.47
Average Shares Outstanding — Basic
4,303
4,309
4,323
Effect of dilutive securities
Average Shares Outstanding — Diluted
4,313
4,320
4,339
Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Consolidated Financial Statements.
THE COCA-COLA COMPANY AND SUBSIDIARIES

Question: What was The Coca-Cola Company's net income in fiscal year 2025?

what was net income in fiscal year 2025?

what was the coca-cola company's net income in fiscal year 2025?

(in millions except per share data) year ended december 31 net operating revenues 47941 47061 45754 cost of goods sold 18397 18324 18520 gross profit 29544 28737 27234 selling general and administrative expenses 14521 14582 13972 other operating charges 1261 4163 1951 operating income 13762 9992 11311 interest income interest expense 1654 1656 1527 equity income (loss) — net 2031 1770 1691 other income (loss) — net 1073 1992 income before income taxes 15998 13086 12952 income taxes 2861 2437 2249 consolidated net income 13137 10649 10703 less: net income (loss) attributable to noncontrolling interests net income attributable to shareowners of the coca-cola company 13107 10631 10714 basic net income per share 3.05 2.47 2.48 diluted net income per share 3.04 2.46 2.47 average shares outstanding — basic 4303 4309 4323 effect of dilutive securities average shares outstanding — diluted 4313 4320 4339 calculated based on net income attributable to shareowners of the coca-cola company. refer to notes to consolidated financial statements. the coca-cola company and subsidiaries


(In millions)
Year Ended December 31,
Operating Activities
Consolidated net income
13,137
10,649
10,703
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization
1,050
1,075
1,128
Stock-based compensation expense
Deferred income taxes
Equity (income) loss — net of dividends
1,038
1,019
Foreign currency adjustments
Significant (gains) losses — net
1,737
Other operating charges
1,052
4,000
1,741
Other items
Net change in operating assets and liabilities
7,208
6,234
Net Cash Provided by Operating Activities
7,408
6,805
11,599
Investing Activities
Purchases of investments
6,160
5,640
6,698
Proceeds from disposals of investments
4,665
6,589
4,354
Acquisitions of businesses, equity method investments and nonmarketable securities
Proceeds from disposals of businesses, equity method investments and nonmarketable securities
3,567
3,485
Purchases of property, plant and equipment
2,112
2,064
1,852
Proceeds from disposals of property, plant and equipment
Collateral (paid) received associated with hedging activities — net
Other investing activities
Net Cash Provided by (Used in) Investing Activities
2,524
3,349
Financing Activities
Issuances of loans, notes payable and long-term debt
4,980
12,061
6,891
Payments of loans, notes payable and long-term debt
4,967
9,533
5,034
Issuances of stock
Purchases of stock for treasury
1,795
2,289
Dividends
8,779
8,359
7,952
Proceeds from sale of a noncontrolling interest
1,338
Other financing activities
Net Cash Provided by (Used in) Financing Activities
8,140
6,910
8,310
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and
Restricted Cash Equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash
equivalents during the year
1,796
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of year
11,488
9,692
9,825
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Year
11,010
11,488
9,692
Less: Restricted cash and restricted cash equivalents at end of year
Cash and Cash Equivalents at End of Year
10,270
10,828
9,366
Refer to Notes to Consolidated Financial Statements.
THE COCA-COLA COMPANY AND SUBSIDIARIES

Question: What was The Coca-Cola Company's operating cash flow in fiscal year 2025?

net cash provided by used in operating activities

what was operating cash flow in fiscal year 2025?

what was the coca-cola company's operating cash flow in fiscal year 2025?

(in millions) year ended december 31 operating activities consolidated net income 13137 10649 10703 adjustments to reconcile consolidated net income to net cash provided by operating activities: depreciation and amortization 1050 1075 1128 stock-based compensation expense deferred income taxes equity (income) loss — net of dividends 1038 1019 foreign currency adjustments significant (gains) losses — net 1737 other operating charges 1052 4000 1741 other items net change in operating assets and liabilities 7208 6234 net cash provided by operating activities 7408 6805 11599 investing activities purchases of investments 6160 5640 6698 proceeds from disposals of investments 4665 6589 4354 acquisitions of businesses equity method investments and nonmarketable securities proceeds from disposals of businesses equity method investments and nonmarketable securities 3567 3485 purchases of property plant and equipment 2112 2064 1852 proceeds from disposals of property plant and equipment collateral (paid) received associated with hedging activities — net other investing activities net cash provided by (used in) investing activities 2524 3349 financing activities issuances of loans notes payable and long-term debt 4980 12061 6891 payments of loans notes payable and long-term debt 4967 9533 5034 issuances of stock purchases of stock for treasury 1795 2289 dividends 8779 8359 7952 proceeds from sale of a noncontrolling interest 1338 other financing activities net cash provided by (used in) financing activities 8140 6910 8310 effect of exchange rate changes on cash cash equivalents restricted cash and restricted cash equivalents cash cash equivalents restricted cash and restricted cash equivalents net increase (decrease) in cash cash equivalents restricted cash and restricted cash equivalents during the year 1796 cash cash equivalents restricted cash and restricted cash equivalents at beginning of year 11488 9692 9825 cash cash equivalents restricted cash and restricted cash equivalents at end of year 11010 11488 9692 less: restricted cash and restricted cash equivalents at end of year cash and cash equivalents at end of year 10270 10828 9366 refer to notes to consolidated financial statements. the coca-cola company and subsidiaries


Question: What was The Coca-Cola Company's revenue in fiscal year 2025?

what was the coca-cola company's revenue in fiscal year 2025?


(In millions except par value)
December 31,
ASSETS
Current Assets
Cash and cash equivalents
10,270
10,828
Short-term investments
3,602
2,020
Total Cash, Cash Equivalents and Short-Term Investments
13,872
12,848
Marketable securities
1,934
1,723
Trade accounts receivable, less allowances of $
and $
, respectively
3,038
3,569
Inventories
4,425
4,728
Prepaid expenses and other current assets
2,433
2,998
Assets held for sale
5,342
Total Current Assets
31,044
25,997
Equity method investments
20,235
18,087
Deferred income tax assets
1,206
1,319
Property, plant and equipment — net
9,613
10,303
Trademarks with indefinite lives
12,531
13,301
Goodwill
15,491
18,139
Other noncurrent assets
14,696
13,403
Total Assets
104,816
100,549
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses
14,813
21,712
Loans and notes payable
1,551
1,499
Current maturities of long-term debt
1,822
Accrued income taxes
1,387
Liabilities held for sale
2,570
Total Current Liabilities
21,281
25,249
Long-term debt
42,119
42,375
Other noncurrent liabilities
4,735
4,084
Deferred income tax liabilities
2,406
2,469
The Coca-Cola Company Shareowners’ Equity
Common stock, $
0.25
par value; authorized —
11,200
shares; issued —
7,040
shares
1,760
Capital surplus
20,581
19,801
Reinvested earnings
80,382
76,054
Accumulated other comprehensive income (loss)
14,131
16,843
Treasury stock, at cost —
2,738
and
2,738
shares, respectively
56,423
55,916
Equity Attributable to Shareowners of The Coca-Cola Company
32,169
24,856
Equity attributable to noncontrolling interests
2,106
1,516
Total Equity
34,275
26,372
Total Liabilities and Equity
104,816
100,549
Refer to Notes to Consolidated Financial Statements.
THE COCA-COLA COMPANY AND SUBSIDIARIES

Question: What was The Coca-Cola Company's total assets in fiscal year 2025?

what was the coca-cola company's total assets in fiscal year 2025?

what was total assets in fiscal year 2025?

(in millions except par value) december 31 assets current assets cash and cash equivalents 10270 10828 short-term investments 3602 2020 total cash cash equivalents and short-term investments 13872 12848 marketable securities 1934 1723 trade accounts receivable less allowances of and respectively 3038 3569 inventories 4425 4728 prepaid expenses and other current assets 2433 2998 assets held for sale 5342 total current assets 31044 25997 equity method investments 20235 18087 deferred income tax assets 1206 1319 property plant and equipment — net 9613 10303 trademarks with indefinite lives 12531 13301 goodwill 15491 18139 other noncurrent assets 14696 13403 total assets 104816 100549 liabilities and equity current liabilities accounts payable and accrued expenses 14813 21712 loans and notes payable 1551 1499 current maturities of long-term debt 1822 accrued income taxes 1387 liabilities held for sale 2570 total current liabilities 21281 25249 long-term debt 42119 42375 other noncurrent liabilities 4735 4084 deferred income tax liabilities 2406 2469 the coca-cola company shareowners' equity common stock 0.25 par value; authorized — 11200 shares; issued — 7040 shares 1760 capital surplus 20581 19801 reinvested earnings 80382 76054 accumulated other comprehensive income (loss) 14131 16843 treasury stock at cost — 2738 and 2738 shares respectively 56423 55916 equity attributable to shareowners of the coca-cola company 32169 24856 equity attributable to noncontrolling interests 2106 1516 total equity 34275 26372 total liabilities and equity 104816 100549 refer to notes to consolidated financial statements. the coca-cola company and subsidiaries


Question: What was The Coca-Cola Company's gross margin in fiscal year 2025?

what was the coca-cola company's gross margin in fiscal year 2025?


Question: What was The Coca-Cola Company's net margin in fiscal year 2025?

what was the coca-cola company's net margin in fiscal year 2025?


Question: What was The Coca-Cola Company's operating cash flow margin in fiscal year 2025?

what was the coca-cola company's operating cash flow margin in fiscal year 2025?


Question: By what percentage did The Coca-Cola Company's net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did the coca-cola company's net income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did The Coca-Cola Company's operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did the coca-cola company's operating income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did The Coca-Cola Company's revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did the coca-cola company's revenue change from fiscal year 2024 to fiscal year 2025?

(in millions except per share data) year ended december 31 net operating revenues 47941 47061 45754 cost of goods sold 18397 18324 18520 gross profit 29544 28737 27234 selling general and administrative expenses 14521 14582 13972 other operating charges 1261 4163 1951 operating income 13762 9992 11311 interest income interest expense 1654 1656 1527 equity income (loss) — net 2031 1770 1691 other income (loss) — net 1073 1992 income before income taxes 15998 13086 12952 income taxes 2861 2437 2249 consolidated net income 13137 10649 10703 less: net income (loss) attributable to noncontrolling interests net income attributable to shareowners of the coca-cola company 13107 10631 10714 basic net income per share 3.05 2.47 2.48 diluted net income per share 3.04 2.46 2.47 average shares outstanding — basic 4303 4309 4323 effect of dilutive securities average shares outstanding — diluted 4313 4320 4339 calculated based on net income attributable to shareowners of the coca-cola company. refer to notes to consolidated financial statements. the coca-cola company and subsidiaries


Amounts in millions except per share amounts; fiscal years ended June 30
NET SALES
84,284
84,039
82,006
Cost of products sold
41,164
40,848
42,760
Selling, general and administrative expense
22,669
23,305
21,112
Indefinite-lived intangible asset impairment charge
1,341
OPERATING INCOME
20,451
18,545
18,134
Interest expense
Interest income
Other non-operating income, net
EARNINGS BEFORE INCOME TAXES
20,167
18,761
18,353
Income taxes
4,102
3,787
3,615
NET EARNINGS
16,065
14,974
14,738
Less: Net earnings attributable to noncontrolling interests
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
15,974
14,879
14,653
NET EARNINGS PER COMMON SHARE
Basic
6.67
6.18
6.07
Diluted
6.51
6.02
5.90
Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

Question: What was The Procter & Gamble Company's net income in fiscal year 2025?

what was net income in fiscal year 2025?

what was the procter & gamble company's net income in fiscal year 2025?

amounts in millions except per share amounts; fiscal years ended june 30 net sales 84284 84039 82006 cost of products sold 41164 40848 42760 selling general and administrative expense 22669 23305 21112 indefinite-lived intangible asset impairment charge 1341 operating income 20451 18545 18134 interest expense interest income other non-operating income net earnings before income taxes 20167 18761 18353 income taxes 4102 3787 3615 net earnings 16065 14974 14738 less: net earnings attributable to noncontrolling interests net earnings attributable to procter & gamble 15974 14879 14653 net earnings per common share basic 6.67 6.18 6.07 diluted 6.51 6.02 5.90 basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to procter & gamble.


Amounts in millions; fiscal years ended June 30
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR
9,482
8,246
7,214
OPERATING ACTIVITIES
Net earnings
16,065
14,974
14,738
Depreciation and amortization
2,847
2,896
2,714
Share-based compensation expense
Deferred income taxes
Loss/(gain) on sale of assets
Indefinite-lived intangible asset impairment charge
1,341
Change in accounts receivable
Change in inventories
Change in accounts payable
Other
1,653
TOTAL OPERATING ACTIVITIES
17,817
19,846
16,848
INVESTING ACTIVITIES
Capital expenditures
3,773
3,322
3,062
Proceeds from asset sales
Acquisitions, net of cash acquired
Other investing activity
TOTAL INVESTING ACTIVITIES
3,818
3,504
3,500
FINANCING ACTIVITIES
Dividends to shareholders
9,872
9,312
8,999
Additions to short-term debt with original maturities of more than three months
8,020
3,528
17,168
Reductions in short-term debt with original maturities of more than three months
6,512
7,689
13,031
Net additions/(reductions) to other short-term debt
1,138
3,319
Additions to long-term debt
2,237
3,197
3,997
Reductions in long-term debt
1,977
2,335
1,878
Treasury stock purchases
6,500
5,006
7,353
Impact of stock options and other
1,707
1,905
1,269
TOTAL FINANCING ACTIVITIES
14,036
14,855
12,146
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
1,235
1,032
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR
9,556
9,482
8,246
SUPPLEMENTAL DISCLOSURE
Cash payments for interest
Cash payments for income taxes
4,554
4,363
4,278
Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the previously reported Total Operating Activities.
See accompanying Notes to Consolidated Financial Statements.
40 The Procter & Gamble Company

Question: What was The Procter & Gamble Company's operating cash flow in fiscal year 2025?

net cash provided by used in operating activities

what was operating cash flow in fiscal year 2025?

what was the procter & gamble company's operating cash flow in fiscal year 2025?

amounts in millions; fiscal years ended june 30 cash cash equivalents and restricted cash beginning of year 9482 8246 7214 operating activities net earnings 16065 14974 14738 depreciation and amortization 2847 2896 2714 share-based compensation expense deferred income taxes loss/(gain) on sale of assets indefinite-lived intangible asset impairment charge 1341 change in accounts receivable change in inventories change in accounts payable other 1653 total operating activities 17817 19846 16848 investing activities capital expenditures 3773 3322 3062 proceeds from asset sales acquisitions net of cash acquired other investing activity total investing activities 3818 3504 3500 financing activities dividends to shareholders 9872 9312 8999 additions to short-term debt with original maturities of more than three months 8020 3528 17168 reductions in short-term debt with original maturities of more than three months 6512 7689 13031 net additions/(reductions) to other short-term debt 1138 3319 additions to long-term debt 2237 3197 3997 reductions in long-term debt 1977 2335 1878 treasury stock purchases 6500 5006 7353 impact of stock options and other 1707 1905 1269 total financing activities 14036 14855 12146 effect of exchange rate changes on cash cash equivalents and restricted cash change in cash cash equivalents and restricted cash 1235 1032 cash cash equivalents and restricted cash end of year 9556 9482 8246 supplemental disclosure cash payments for interest cash payments for income taxes 4554 4363 4278 certain prior period amounts within operating activities have been reclassified for consistency with the current period presentation. these reclassifications had no effect on the previously reported total operating activities. see accompanying notes to consolidated financial statements. 40 the procter & gamble company


Question: What was The Procter & Gamble Company's revenue in fiscal year 2025?

what was the procter & gamble company's revenue in fiscal year 2025?


Amounts in millions except stated values; as of June 30
Assets
CURRENT ASSETS
Cash and cash equivalents
9,556
9,482
Accounts receivable
6,185
6,118
INVENTORIES
Materials and supplies
2,022
1,617
Work in process
1,012
Finished goods
4,516
4,470
Total inventories
7,551
7,016
Prepaid expenses and other current assets
2,100
2,095
TOTAL CURRENT ASSETS
25,392
24,709
PROPERTY, PLANT AND EQUIPMENT, NET
23,897
22,152
GOODWILL
41,650
40,303
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET
21,910
22,047
OTHER NONCURRENT ASSETS
12,381
13,158
TOTAL ASSETS
125,231
122,370
Liabilities and Shareholders' Equity
CURRENT LIABILITIES
Accounts payable
15,227
15,364
Accrued and other liabilities
11,318
11,073
Debt due within one year
9,513
7,191
TOTAL CURRENT LIABILITIES
36,058
33,627
LONG-TERM DEBT
24,995
25,269
DEFERRED INCOME TAXES
5,774
6,516
OTHER NONCURRENT LIABILITIES
6,120
6,398
TOTAL LIABILITIES
72,946
71,811
SHAREHOLDERS' EQUITY
Convertible Class A preferred stock, stated value $
per share (
shares authorized)
Non-Voting Class B preferred stock, stated value $
per share (
shares authorized)
Common stock, stated value $
per share (
10,000
shares authorized; shares issued: 2025 -
4,009.2
, 2024 -
4,009.2
4,009
Additional paid-in capital
68,770
67,684
Reserve for ESOP debt retirement
Accumulated other comprehensive loss
12,143
11,900
Treasury stock (shares held: 2025 -
1,667.3
; 2024 -
1,652.2
138,702
133,379
Retained earnings
129,973
123,811
Noncontrolling interest
TOTAL SHAREHOLDERS' EQUITY
52,284
50,559
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
125,231
122,370
See accompanying Notes to Consolidated Financial Statements.
38 The Procter & Gamble Company

Question: What was The Procter & Gamble Company's total assets in fiscal year 2025?

what was the procter & gamble company's total assets in fiscal year 2025?

what was total assets in fiscal year 2025?

amounts in millions except stated values; as of june 30 assets current assets cash and cash equivalents 9556 9482 accounts receivable 6185 6118 inventories materials and supplies 2022 1617 work in process 1012 finished goods 4516 4470 total inventories 7551 7016 prepaid expenses and other current assets 2100 2095 total current assets 25392 24709 property plant and equipment net 23897 22152 goodwill 41650 40303 trademarks and other intangible assets net 21910 22047 other noncurrent assets 12381 13158 total assets 125231 122370 liabilities and shareholders' equity current liabilities accounts payable 15227 15364 accrued and other liabilities 11318 11073 debt due within one year 9513 7191 total current liabilities 36058 33627 long-term debt 24995 25269 deferred income taxes 5774 6516 other noncurrent liabilities 6120 6398 total liabilities 72946 71811 shareholders' equity convertible class a preferred stock stated value per share ( shares authorized) non-voting class b preferred stock stated value per share ( shares authorized) common stock stated value per share ( 10000 shares authorized; shares issued: 2025 - 4009.2 2024 - 4009.2 4009 additional paid-in capital 68770 67684 reserve for esop debt retirement accumulated other comprehensive loss 12143 11900 treasury stock (shares held: 2025 - 1667.3 ; 2024 - 1652.2 138702 133379 retained earnings 129973 123811 noncontrolling interest total shareholders' equity 52284 50559 total liabilities and shareholders' equity 125231 122370 see accompanying notes to consolidated financial statements. 38 the procter & gamble company


Question: What was The Procter & Gamble Company's gross margin in fiscal year 2025?

what was the procter & gamble company's gross margin in fiscal year 2025?


Question: What was The Procter & Gamble Company's net margin in fiscal year 2025?

what was the procter & gamble company's net margin in fiscal year 2025?


Question: What was The Procter & Gamble Company's operating cash flow margin in fiscal year 2025?

what was the procter & gamble company's operating cash flow margin in fiscal year 2025?


Question: By what percentage did The Procter & Gamble Company's net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did the procter & gamble company's net income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did The Procter & Gamble Company's operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did the procter & gamble company's operating income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did The Procter & Gamble Company's revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did the procter & gamble company's revenue change from fiscal year 2024 to fiscal year 2025?

amounts in millions except per share amounts; fiscal years ended june 30 net sales 84284 84039 82006 cost of products sold 41164 40848 42760 selling general and administrative expense 22669 23305 21112 indefinite-lived intangible asset impairment charge 1341 operating income 20451 18545 18134 interest expense interest income other non-operating income net earnings before income taxes 20167 18761 18353 income taxes 4102 3787 3615 net earnings 16065 14974 14738 less: net earnings attributable to noncontrolling interests net earnings attributable to procter & gamble 15974 14879 14653 net earnings per common share basic 6.67 6.18 6.07 diluted 6.51 6.02 5.90 basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to procter & gamble.


(millions of dollars)
Note
Reference
Number
Revenues and other income
Sales and other operating revenue
323,905
339,247
334,697
Income from equity affiliates
5,064
6,194
6,385
Other income
3,269
4,144
3,500
Total revenues and other income
332,238
349,585
344,582
Costs and other deductions
Crude oil and product purchases
184,248
199,454
193,029
Production and manufacturing expenses
42,424
39,609
36,885
Selling, general and administrative expenses
11,128
9,976
9,919
Depreciation and depletion (includes impairments)
25,993
23,442
20,641
Exploration expenses, including dry holes
1,007
Non-service pension and postretirement benefit expense
Interest expense
Other taxes and duties
25,167
26,288
29,011
Total costs and other deductions
290,970
300,712
291,799
Income (loss) before income taxes
41,268
48,873
52,783
Income tax expense (benefit)
11,504
13,810
15,429
Net income (loss) including noncontrolling interests
29,764
35,063
37,354
Net income (loss) attributable to noncontrolling interests
1,383
1,344
Net income (loss) attributable to ExxonMobil
28,844
33,680
36,010
Earnings (loss) per common share
(dollars)
6.70
7.84
8.89
Earnings (loss) per common share - assuming dilution
(dollars)
6.70
7.84
8.89
The information in the Notes to Consolidated Financial Statements is an integral part of these statements.

Question: What was Exxon Mobil Corporation's net income in fiscal year 2025?

what was exxon mobil corporation's net income in fiscal year 2025?

what was net income in fiscal year 2025?

(millions of dollars) note reference number revenues and other income sales and other operating revenue 323905 339247 334697 income from equity affiliates 5064 6194 6385 other income 3269 4144 3500 total revenues and other income 332238 349585 344582 costs and other deductions crude oil and product purchases 184248 199454 193029 production and manufacturing expenses 42424 39609 36885 selling general and administrative expenses 11128 9976 9919 depreciation and depletion (includes impairments) 25993 23442 20641 exploration expenses including dry holes 1007 non-service pension and postretirement benefit expense interest expense other taxes and duties 25167 26288 29011 total costs and other deductions 290970 300712 291799 income (loss) before income taxes 41268 48873 52783 income tax expense (benefit) 11504 13810 15429 net income (loss) including noncontrolling interests 29764 35063 37354 net income (loss) attributable to noncontrolling interests 1383 1344 net income (loss) attributable to exxonmobil 28844 33680 36010 earnings (loss) per common share (dollars) 6.70 7.84 8.89 earnings (loss) per common share - assuming dilution (dollars) 6.70 7.84 8.89 the information in the notes to consolidated financial statements is an integral part of these statements.


(millions of dollars)
Note Reference Number
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) including noncontrolling interests
29,764
35,063
37,354
Adjustments for noncash transactions
Depreciation and depletion (includes impairments)
25,993
23,442
20,641
Deferred income tax charges/(credits)
Postretirement benefits expense in excess of/(less than) net payments
Other long-term obligation provisions in excess of/(less than) payments
1,430
1,712
1,501
Dividends received greater than/(less than) equity in current earnings of equity companies
3,006
Changes in operational working capital, excluding cash and debt
Notes and accounts receivable
reduction/(increase)
3,042
6,030
4,370
Inventories
reduction/(increase)
4,300
1,812
3,472
Other current assets
reduction/(increase)
Accounts and other payables
increase/(reduction)
5,627
4,727
Net (gain)/loss on asset sales
1,113
1,223
All other items - net
2,777
2,310
2,410
Net cash provided by operating activities
51,970
55,022
55,369
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant, and equipment
28,358
24,306
21,919
Proceeds from asset sales and returns of investments
3,158
4,987
4,078
Additional investments and advances
4,133
3,299
2,995
Other investing activities including collection of advances
3,406
1,926
1,562
Cash acquired from mergers and acquisitions
Net cash used in investing activities
25,927
19,938
19,274
CASH FLOWS FROM FINANCING ACTIVITIES
Additions to long-term debt
2,311
Reductions in long-term debt
1,108
1,150
Additions to short-term debt
2,359
Reductions in short-term debt
5,404
4,743
Additions/(reductions) in commercial paper, and debt with three months or less maturity
1,895
Contingent consideration payments
Cash dividends to ExxonMobil shareholders
17,231
16,704
14,941
Cash dividends to noncontrolling interests
Changes in noncontrolling interests
Inflows from noncontrolling interests for major projects
Common stock acquired
20,273
19,629
17,748
Net cash provided by (used in) financing activities
39,081
42,789
34,297
Effects of exchange rate changes on cash
Increase/(decrease) in cash and cash equivalents (including restricted)
12,506
8,381
1,903
Cash and cash equivalents at beginning of year (including restricted)
23,187
31,568
29,665
Cash and cash equivalents at end of year (including restricted)
10,681
23,187
31,568
Includes $
million issued to facilitate the sale of an entity where the buyer assumed the debt upon closing; no longer on the Consolidated Balance Sheet at the end of 2023.
Includes $
million of proceeds related to a financing arrangement to facilitate the sale of an entity where the buyer assumed the obligation at closing; no longer on the Consolidated Balance Sheet at the end of 2025.
Includes commercial paper with a maturity greater than three months.
Non-Cash Transaction:

Question: What was Exxon Mobil Corporation's operating cash flow in fiscal year 2025?

net cash provided by used in operating activities

what was exxon mobil corporation's operating cash flow in fiscal year 2025?

what was operating cash flow in fiscal year 2025?

(millions of dollars) note reference number cash flows from operating activities net income (loss) including noncontrolling interests 29764 35063 37354 adjustments for noncash transactions depreciation and depletion (includes impairments) 25993 23442 20641 deferred income tax charges/(credits) postretirement benefits expense in excess of/(less than) net payments other long-term obligation provisions in excess of/(less than) payments 1430 1712 1501 dividends received greater than/(less than) equity in current earnings of equity companies 3006 changes in operational working capital excluding cash and debt notes and accounts receivable reduction/(increase) 3042 6030 4370 inventories reduction/(increase) 4300 1812 3472 other current assets reduction/(increase) accounts and other payables increase/(reduction) 5627 4727 net (gain)/loss on asset sales 1113 1223 all other items - net 2777 2310 2410 net cash provided by operating activities 51970 55022 55369 cash flows from investing activities additions to property plant and equipment 28358 24306 21919 proceeds from asset sales and returns of investments 3158 4987 4078 additional investments and advances 4133 3299 2995 other investing activities including collection of advances 3406 1926 1562 cash acquired from mergers and acquisitions net cash used in investing activities 25927 19938 19274 cash flows from financing activities additions to long-term debt 2311 reductions in long-term debt 1108 1150 additions to short-term debt 2359 reductions in short-term debt 5404 4743 additions/(reductions) in commercial paper and debt with three months or less maturity 1895 contingent consideration payments cash dividends to exxonmobil shareholders 17231 16704 14941 cash dividends to noncontrolling interests changes in noncontrolling interests inflows from noncontrolling interests for major projects common stock acquired 20273 19629 17748 net cash provided by (used in) financing activities 39081 42789 34297 effects of exchange rate changes on cash increase/(decrease) in cash and cash equivalents (including restricted) 12506 8381 1903 cash and cash equivalents at beginning of year (including restricted) 23187 31568 29665 cash and cash equivalents at end of year (including restricted) 10681 23187 31568 includes million issued to facilitate the sale of an entity where the buyer assumed the debt upon closing; no longer on the consolidated balance sheet at the end of 2023. includes million of proceeds related to a financing arrangement to facilitate the sale of an entity where the buyer assumed the obligation at closing; no longer on the consolidated balance sheet at the end of 2025. includes commercial paper with a maturity greater than three months. non-cash transaction:


(millions of dollars)
Note
Reference
Number
December 31, 2025
December 31, 2024
ASSETS
Current assets
Cash and cash equivalents
10,681
23,029
Cash and cash equivalents – restricted
Notes and accounts receivable – net
44,562
43,681
Inventories
Crude oil, products and merchandise
22,979
19,444
Materials and supplies
3,323
4,080
Other current assets
1,837
1,598
Total current assets
83,382
91,990
Investments, advances, and long-term receivables
45,317
47,200
Property, plant, and equipment, at cost, less accumulated depreciation and depletion
299,373
294,318
Other assets, including intangibles – net
20,908
19,967
Total Assets
448,980
453,475
LIABILITIES
Current liabilities
Notes and loans payable
9,296
4,955
Accounts payable and accrued liabilities
60,911
61,297
Income taxes payable
2,123
4,055
Total current liabilities
72,330
70,307
Long-term debt
34,241
36,755
Postretirement benefits reserves
8,847
9,700
Deferred income tax liabilities
40,216
39,042
Long-term obligations to equity companies
1,346
Other long-term obligations
26,178
25,719
Total Liabilities
182,354
182,869
Commitments and contingencies
EQUITY
Common stock without par value
9,000
million shares authorized,
8,019
million shares issued)
46,150
46,238
Earnings reinvested
482,494
470,903
Accumulated other comprehensive income
10,863
14,619
Common stock held in treasury
3,840
million shares in 2025 and
3,666
million shares in 2024)
258,395
238,817
ExxonMobil share of equity
259,386
263,705
Noncontrolling interests
7,240
6,901
Total Equity
266,626
270,606
Total Liabilities and Equity
448,980
453,475
The information in the Notes to Consolidated Financial Statements is an integral part of these statements.

Question: What was Exxon Mobil Corporation's total assets in fiscal year 2025?

what was exxon mobil corporation's total assets in fiscal year 2025?

what was total assets in fiscal year 2025?

(millions of dollars) note reference number december 31 2025 december 31 2024 assets current assets cash and cash equivalents 10681 23029 cash and cash equivalents – restricted notes and accounts receivable – net 44562 43681 inventories crude oil products and merchandise 22979 19444 materials and supplies 3323 4080 other current assets 1837 1598 total current assets 83382 91990 investments advances and long-term receivables 45317 47200 property plant and equipment at cost less accumulated depreciation and depletion 299373 294318 other assets including intangibles – net 20908 19967 total assets 448980 453475 liabilities current liabilities notes and loans payable 9296 4955 accounts payable and accrued liabilities 60911 61297 income taxes payable 2123 4055 total current liabilities 72330 70307 long-term debt 34241 36755 postretirement benefits reserves 8847 9700 deferred income tax liabilities 40216 39042 long-term obligations to equity companies 1346 other long-term obligations 26178 25719 total liabilities 182354 182869 commitments and contingencies equity common stock without par value 9000 million shares authorized 8019 million shares issued) 46150 46238 earnings reinvested 482494 470903 accumulated other comprehensive income 10863 14619 common stock held in treasury 3840 million shares in 2025 and 3666 million shares in 2024) 258395 238817 exxonmobil share of equity 259386 263705 noncontrolling interests 7240 6901 total equity 266626 270606 total liabilities and equity 448980 453475 the information in the notes to consolidated financial statements is an integral part of these statements.


Question: By what percentage did Exxon Mobil Corporation's net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did exxon mobil corporation's net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did net income change from fiscal year 2024 to fiscal year 2025?


Pfizer Inc. and Subsidiary Companies
Year Ended December 31,
(MILLIONS, EXCEPT PER SHARE DATA)
Revenues:
Product revenues
51,663
53,816
50,914
Alliance revenues
9,266
8,388
7,582
Royalty revenues
1,650
1,423
1,058
Total revenues
62,579
63,627
59,553
Costs and expenses:
Cost of sales
(a), (b)
16,067
17,851
24,954
Selling, informational and administrative expenses
(a)
13,794
14,730
14,771
Research and development expenses
(a)
10,437
10,822
10,679
Acquired in-process research and development expenses
1,613
Amortization of intangible assets
4,874
5,286
4,733
Restructuring charges and certain acquisition-related costs
1,550
2,419
2,943
Other (income)/deductions––net
6,724
4,388
Income from continuing operations before provision/(benefit) for taxes on income
7,520
8,023
1,058
Provision/(benefit) for taxes on income
1,115
Income from continuing operations
7,787
8,051
2,172
Discontinued operations––net of tax
Net income before allocation to noncontrolling interests
7,812
8,062
2,158
Less: Net income attributable to noncontrolling interests
Net income attributable to Pfizer Inc. common shareholders
7,771
8,031
2,119
Earnings per common share––basic
Income from continuing operations attributable to Pfizer Inc. common shareholders
1.37
1.42
0.38
Discontinued operations––net of tax
Net income attributable to Pfizer Inc. common shareholders
1.37
1.42
0.38
Earnings per common share––diluted
Income from continuing operations attributable to Pfizer Inc. common shareholders
1.36
1.41
0.37
Discontinued operations––net of tax
Net income attributable to Pfizer Inc. common shareholders
1.36
1.41
0.37
Weighted-average shares––basic
5,683
5,664
5,643
Weighted-average shares––diluted
5,713
5,700
5,709
(a)
Exclusive of amortization of intangible assets.
(b)
See
Note
17A
See Accompanying Notes.
Pfizer Inc.
2025 Form 10-K

Question: What was Pfizer Inc.'s net income in fiscal year 2025?

what was pfizer inc.'s net income in fiscal year 2025?

pfizer inc. and subsidiary companies year ended december 31 (millions except per share data) revenues: product revenues 51663 53816 50914 alliance revenues 9266 8388 7582 royalty revenues 1650 1423 1058 total revenues 62579 63627 59553 costs and expenses: cost of sales (a) (b) 16067 17851 24954 selling informational and administrative expenses (a) 13794 14730 14771 research and development expenses (a) 10437 10822 10679 acquired in-process research and development expenses 1613 amortization of intangible assets 4874 5286 4733 restructuring charges and certain acquisition-related costs 1550 2419 2943 other (income)/deductions––net 6724 4388 income from continuing operations before provision/(benefit) for taxes on income 7520 8023 1058 provision/(benefit) for taxes on income 1115 income from continuing operations 7787 8051 2172 discontinued operations––net of tax net income before allocation to noncontrolling interests 7812 8062 2158 less: net income attributable to noncontrolling interests net income attributable to pfizer inc. common shareholders 7771 8031 2119 earnings per common share––basic income from continuing operations attributable to pfizer inc. common shareholders 1.37 1.42 0.38 discontinued operations––net of tax net income attributable to pfizer inc. common shareholders 1.37 1.42 0.38 earnings per common share––diluted income from continuing operations attributable to pfizer inc. common shareholders 1.36 1.41 0.37 discontinued operations––net of tax net income attributable to pfizer inc. common shareholders 1.36 1.41 0.37 weighted-average shares––basic 5683 5664 5643 weighted-average shares––diluted 5713 5700 5709 (a) exclusive of amortization of intangible assets. (b) see note 17a see accompanying notes. pfizer inc. 2025 form 10-k


Pfizer Inc. and Subsidiary Companies
Year Ended December 31,
(MILLIONS)
Operating Activities
Net income before allocation to noncontrolling interests
7,812
8,062
2,158
Discontinued operations—net of tax
Net income from continuing operations before allocation to noncontrolling interests
7,787
8,051
2,172
Adjustments to reconcile net income from continuing operations before allocation to noncontrolling interests to net cash provided by/(used in) operating activities:
Depreciation and amortization
6,592
7,013
6,290
Asset write-offs and impairments
5,270
4,242
3,408
Deferred taxes
2,133
2,102
3,442
Share-based compensation expense
Benefit plan contributions in excess of expense/income
Inventory write-offs and related charges associated with COVID-19 products
(a)
6,199
Other adjustments, net
2,260
3,492
Other changes in assets and liabilities, net of acquisitions and divestitures:
Trade accounts receivable
Inventories
(a)
1,169
Other assets
1,289
3,380
Trade accounts payable
1,023
Other liabilities
(b)
3,667
3,115
Other tax accounts, net
2,805
1,345
Net cash provided by/(used in) operating activities
11,704
12,744
8,700
Investing Activities
Purchases of property, plant and equipment
2,629
2,909
3,907
Purchases of short-term investments
14,356
10,133
30,974
Proceeds from redemptions/sales of short-term investments
17,959
4,128
39,264
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less
2,675
3,136
5,174
Purchases of long-term investments
Proceeds from redemptions/sales of long-term investments
1,095
1,570
1,979
Proceeds from partial sales of investment in Haleon
(c)
6,311
7,040
Acquisitions of businesses, net of cash acquired
6,927
43,430
Other investing activities, net
Net cash provided by/(used in) investing activities
1,351
2,652
32,278
Financing Activities
Proceeds from short-term borrowings
8,907
4,525
Payments on short-term borrowings
2,199
11,226
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less
2,590
3,161
Proceeds from issuance of long-term debt
9,678
30,831
Payments on long-term debt
6,757
2,250
2,569
Cash dividends paid
9,771
9,512
9,247
Other financing activities, net
Net cash provided by/(used in) financing activities
10,304
17,140
26,066
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents
1,810
2,448
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period
1,107
2,917
Cash and cash equivalents and restricted cash and cash equivalents, at end of period
1,197
1,107
2,917
- Continued -
Pfizer Inc.
2025 Form 10-K

Question: What was Pfizer Inc.'s operating cash flow in fiscal year 2025?

what was pfizer inc.'s operating cash flow in fiscal year 2025?

pfizer inc. and subsidiary companies year ended december 31 (millions) operating activities net income before allocation to noncontrolling interests 7812 8062 2158 discontinued operations—net of tax net income from continuing operations before allocation to noncontrolling interests 7787 8051 2172 adjustments to reconcile net income from continuing operations before allocation to noncontrolling interests to net cash provided by/(used in) operating activities: depreciation and amortization 6592 7013 6290 asset write-offs and impairments 5270 4242 3408 deferred taxes 2133 2102 3442 share-based compensation expense benefit plan contributions in excess of expense/income inventory write-offs and related charges associated with covid-19 products (a) 6199 other adjustments net 2260 3492 other changes in assets and liabilities net of acquisitions and divestitures: trade accounts receivable inventories (a) 1169 other assets 1289 3380 trade accounts payable 1023 other liabilities (b) 3667 3115 other tax accounts net 2805 1345 net cash provided by/(used in) operating activities 11704 12744 8700 investing activities purchases of property plant and equipment 2629 2909 3907 purchases of short-term investments 14356 10133 30974 proceeds from redemptions/sales of short-term investments 17959 4128 39264 net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less 2675 3136 5174 purchases of long-term investments proceeds from redemptions/sales of long-term investments 1095 1570 1979 proceeds from partial sales of investment in haleon (c) 6311 7040 acquisitions of businesses net of cash acquired 6927 43430 other investing activities net net cash provided by/(used in) investing activities 1351 2652 32278 financing activities proceeds from short-term borrowings 8907 4525 payments on short-term borrowings 2199 11226 net (payments on)/proceeds from short-term borrowings with original maturities of three months or less 2590 3161 proceeds from issuance of long-term debt 9678 30831 payments on long-term debt 6757 2250 2569 cash dividends paid 9771 9512 9247 other financing activities net net cash provided by/(used in) financing activities 10304 17140 26066 effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents 1810 2448 cash and cash equivalents and restricted cash and cash equivalents at beginning of period 1107 2917 cash and cash equivalents and restricted cash and cash equivalents at end of period 1197 1107 2917 - continued - pfizer inc. 2025 form 10-k


Pfizer Inc. and Subsidiary Companies
As of December 31,
(MILLIONS, EXCEPT PER SHARE DATA)
Assets
Cash and cash equivalents
1,142
1,043
Short-term investments
12,454
19,434
Trade accounts receivable, net of allowance for doubtful accounts: 2025—$
; 2024—$
11,874
11,463
Inventories
10,654
10,851
Current tax assets
3,967
3,314
Other current assets
2,808
4,253
Total current assets
42,898
50,358
Long-term investments
1,621
2,228
Property, plant and equipment, net
19,317
18,393
Identifiable intangible assets, net
53,731
55,411
Goodwill
71,264
68,527
Noncurrent deferred tax assets and other noncurrent tax assets
9,699
8,662
Other noncurrent assets
9,631
9,817
Total assets
208,160
213,396
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2025—$
2,997
; 2024—$
3,747
3,154
6,946
Trade accounts payable
5,240
5,633
Dividends payable
2,445
2,437
Income taxes payable
3,103
2,910
Accrued compensation and related items
3,610
3,838
Deferred revenues
1,511
Other current liabilities
18,648
19,720
Total current liabilities
36,984
42,995
Long-term debt
61,641
57,405
Pension and postretirement benefit obligations
2,041
2,115
Noncurrent deferred tax liabilities
2,401
2,122
Other taxes payable
3,591
6,112
Other noncurrent liabilities
14,725
14,150
Total liabilities
121,385
124,899
Commitments and Contingencies
Common stock, $
0.05
par value;
12,000
shares authorized; issued: 2025—
9,621
; 2024—
9,593
Additional paid-in capital
94,469
93,603
Treasury stock, shares at cost: 2025—
3,935
; 2024—
3,926
115,015
114,763
Retained earnings
114,610
116,725
Accumulated other comprehensive loss
8,069
7,842
Total Pfizer Inc. shareholders’ equity
86,476
88,203
Equity attributable to noncontrolling interests
Total equity
86,775
88,497
Total liabilities and equity
208,160
213,396
See Accompanying Notes.
Pfizer Inc.
2025 Form 10-K

Question: What was Pfizer Inc.'s total assets in fiscal year 2025?

what was pfizer inc.'s total assets in fiscal year 2025?

pfizer inc. and subsidiary companies as of december 31 (millions except per share data) assets cash and cash equivalents 1142 1043 short-term investments 12454 19434 trade accounts receivable net of allowance for doubtful accounts: 2025— ; 2024— 11874 11463 inventories 10654 10851 current tax assets 3967 3314 other current assets 2808 4253 total current assets 42898 50358 long-term investments 1621 2228 property plant and equipment net 19317 18393 identifiable intangible assets net 53731 55411 goodwill 71264 68527 noncurrent deferred tax assets and other noncurrent tax assets 9699 8662 other noncurrent assets 9631 9817 total assets 208160 213396 liabilities and equity short-term borrowings including current portion of long-term debt: 2025— 2997 ; 2024— 3747 3154 6946 trade accounts payable 5240 5633 dividends payable 2445 2437 income taxes payable 3103 2910 accrued compensation and related items 3610 3838 deferred revenues 1511 other current liabilities 18648 19720 total current liabilities 36984 42995 long-term debt 61641 57405 pension and postretirement benefit obligations 2041 2115 noncurrent deferred tax liabilities 2401 2122 other taxes payable 3591 6112 other noncurrent liabilities 14725 14150 total liabilities 121385 124899 commitments and contingencies common stock 0.05 par value; 12000 shares authorized; issued: 2025— 9621 ; 2024— 9593 additional paid-in capital 94469 93603 treasury stock shares at cost: 2025— 3935 ; 2024— 3926 115015 114763 retained earnings 114610 116725 accumulated other comprehensive loss 8069 7842 total pfizer inc. shareholders' equity 86476 88203 equity attributable to noncontrolling interests total equity 86775 88497 total liabilities and equity 208160 213396 see accompanying notes. pfizer inc. 2025 form 10-k


Question: By what percentage did Pfizer Inc.'s net income change from fiscal year 2024 to fiscal year 2025?

by what percentage did pfizer inc.'s net income change from fiscal year 2024 to fiscal year 2025?


Consolidated Statement of Cash Flow for the Years Ended December 31,

(Millions of dollars)
Cash flow from operating activities:
Profit of consolidated and affiliated companies
8,882
10,788
10,332
Adjustments to reconcile profit to net cash provided by operating activities:
Depreciation and amortization
2,262
2,153
2,144
Actuarial (gain) loss on pension and postretirement benefits
Provision (benefit) for deferred income taxes
(Gain) loss on divestiture
Other
Changes in assets and liabilities, net of acquisitions and divestitures:
Receivables
trade and other
2,138
Inventories
1,477
Accounts payable
1,179
Accrued expenses
Accrued wages, salaries and employee benefits
Customer advances
1,933
Other assets
net
Other liabilities
net
Net cash provided by (used for) operating activities
11,739
12,035
12,885
Cash flow from investing activities:
Capital expenditures
excluding equipment leased to others
2,821
1,988
1,597
Expenditures for equipment leased to others
1,465
1,227
1,495
Proceeds from disposals of leased assets and property, plant and equipment
Additions to finance receivables
15,329
15,409
15,161
Collections of finance receivables
13,515
13,608
14,034
Proceeds from sale of finance receivables
Investments and acquisitions (net of cash acquired)
Proceeds from sale of businesses and investments (net of cash sold)
Proceeds from maturities and sale of securities
2,494
3,155
1,891
Investments in securities
1,930
1,495
4,405
Other
net
Net cash provided by (used for) investing activities
4,707
2,453
5,871
Cash flow from financing activities:
Dividends paid
2,749
2,646
2,563
Common stock issued, and other stock compensation transactions, net
Payments to purchase common stock
5,190
7,697
4,975
Excise tax paid on purchases of common stock
Proceeds from debt issued (original maturities greater than three months):
- Machinery, Power & Energy
1,976
- Financial Products
9,129
10,283
8,257
Payments on debt (original maturities greater than three months):
- Machinery, Power & Energy
1,032
- Financial Products
8,030
8,284
6,212
Short-term borrowings
net (original maturities three months or less)
1,106
1,345
Other
net
Net cash provided by (used for) financing activities
3,899
9,565
6,932
Effect of exchange rate changes on cash
Increase (decrease) in cash, cash equivalents and restricted cash
3,090
Cash, cash equivalents and restricted cash at beginning of period
6,896
6,985
7,013
Cash, cash equivalents and restricted cash at end of period
9,986
6,896
6,985
Cash equivalents primarily represent short-term, highly liquid investments with original maturities of generally three months or less
See accompanying notes to Consolidated Financial Statements.

Question: What was Caterpillar Inc.'s operating cash flow in fiscal year 2025?

what was caterpillar inc.'s operating cash flow in fiscal year 2025?

(millions of dollars) cash flow from operating activities: profit of consolidated and affiliated companies 8882 10788 10332 adjustments to reconcile profit to net cash provided by operating activities: depreciation and amortization 2262 2153 2144 actuarial (gain) loss on pension and postretirement benefits provision (benefit) for deferred income taxes (gain) loss on divestiture other changes in assets and liabilities net of acquisitions and divestitures: receivables trade and other 2138 inventories 1477 accounts payable 1179 accrued expenses accrued wages salaries and employee benefits customer advances 1933 other assets net other liabilities net net cash provided by (used for) operating activities 11739 12035 12885 cash flow from investing activities: capital expenditures excluding equipment leased to others 2821 1988 1597 expenditures for equipment leased to others 1465 1227 1495 proceeds from disposals of leased assets and property plant and equipment additions to finance receivables 15329 15409 15161 collections of finance receivables 13515 13608 14034 proceeds from sale of finance receivables investments and acquisitions (net of cash acquired) proceeds from sale of businesses and investments (net of cash sold) proceeds from maturities and sale of securities 2494 3155 1891 investments in securities 1930 1495 4405 other net net cash provided by (used for) investing activities 4707 2453 5871 cash flow from financing activities: dividends paid 2749 2646 2563 common stock issued and other stock compensation transactions net payments to purchase common stock 5190 7697 4975 excise tax paid on purchases of common stock proceeds from debt issued (original maturities greater than three months): - machinery power & energy 1976 - financial products 9129 10283 8257 payments on debt (original maturities greater than three months): - machinery power & energy 1032 - financial products 8030 8284 6212 short-term borrowings net (original maturities three months or less) 1106 1345 other net net cash provided by (used for) financing activities 3899 9565 6932 effect of exchange rate changes on cash increase (decrease) in cash cash equivalents and restricted cash 3090 cash cash equivalents and restricted cash at beginning of period 6896 6985 7013 cash cash equivalents and restricted cash at end of period 9986 6896 6985 cash equivalents primarily represent short-term highly liquid investments with original maturities of generally three months or less see accompanying notes to consolidated financial statements.


(Dollars in millions except per share data)
Sales and revenues:
Sales of Machinery, Power & Energy
63,980
61,363
63,869
Revenues of Financial Products
3,609
3,446
3,191
Total sales and revenues
67,589
64,809
67,060
Operating costs:
Cost of goods sold
44,752
40,199
42,767
Selling, general and administrative expenses
6,985
6,667
6,371
Research and development expenses
2,148
2,107
2,108
Interest expense of Financial Products
1,359
1,286
1,030
Other operating (income) expenses
1,194
1,478
1,818
Total operating costs
56,438
51,737
54,094
Operating profit
11,151
13,072
12,966
Interest expense excluding Financial Products
Other income (expense)
Consolidated profit before taxes
11,541
13,373
13,050
Provision (benefit) for income taxes
2,768
2,629
2,781
Profit of consolidated companies
8,773
10,744
10,269
Equity in profit (loss) of unconsolidated affiliated companies
Profit of consolidated and affiliated companies
8,882
10,788
10,332
Less: Profit (loss) attributable to noncontrolling interests
Profit
8,884
10,792
10,335
Profit per common share
18.90
22.17
20.24
Profit per common share — diluted
18.81
22.05
20.12
Weighted-average common shares outstanding (millions)
- Basic
470.0
486.7
510.6
- Diluted
472.3
489.4
513.6
Profit attributable to common shareholders.
Diluted by assumed exercise of stock-based compensation awards using the treasury stock method.
See accompanying notes to Consolidated Financial Statements.
STATEMENT 2
Caterpillar Inc.
Consolidated Comprehensive Income (Loss) for the Years Ended December 31,
(Millions of dollars)
Profit (loss) of consolidated and affiliated companies
8,882
10,788
10,332
Other comprehensive income (loss), net of tax (Note 17):
Foreign currency translation:
Pension and other postretirement benefits:
Derivative financial instruments:
Available-for-sale securities:
Total other comprehensive income (loss), net of tax
Comprehensive income (loss)
9,581
10,137
10,969
Less: comprehensive income (loss) attributable to the noncontrolling interests
Comprehensive income (loss) attributable to shareholders
9,583
10,141
10,972
See accompanying notes to Consolidated Financial Statements.
STATEMENT 3
Caterpillar Inc.
Consolidated Financial Position at December 31,
(Dollars in millions)
Assets
Current assets:
Cash and cash equivalents
9,980
6,889
Receivables – trade and other
10,920
9,282
Receivables – finance
10,649
9,565
Prepaid expenses and other current assets
2,801
3,119
Inventories
18,135
16,827
Total current assets
52,485
45,682
Property, plant and equipment – net
15,140
13,361
Long-term receivables – trade and other
2,142
1,225
Long-term receivables – finance
14,272
13,242
Noncurrent deferred and refundable income taxes
2,882
3,312
Intangible assets
Goodwill
5,321
5,241
Other assets
6,102
5,302
Total assets
98,585
87,764
Liabilities
Current liabilities:
Short-term borrowings:
Financial Products
5,514
4,393
Accounts payable
8,968
7,675
Accrued expenses
5,587
5,243

Question: What was Caterpillar Inc.'s revenue in fiscal year 2025?

what was caterpillar inc.'s revenue in fiscal year 2025?

(dollars in millions except per share data) sales and revenues: sales of machinery power & energy 63980 61363 63869 revenues of financial products 3609 3446 3191 total sales and revenues 67589 64809 67060 operating costs: cost of goods sold 44752 40199 42767 selling general and administrative expenses 6985 6667 6371 research and development expenses 2148 2107 2108 interest expense of financial products 1359 1286 1030 other operating (income) expenses 1194 1478 1818 total operating costs 56438 51737 54094 operating profit 11151 13072 12966 interest expense excluding financial products other income (expense) consolidated profit before taxes 11541 13373 13050 provision (benefit) for income taxes 2768 2629 2781 profit of consolidated companies 8773 10744 10269 equity in profit (loss) of unconsolidated affiliated companies profit of consolidated and affiliated companies 8882 10788 10332 less: profit (loss) attributable to noncontrolling interests profit 8884 10792 10335 profit per common share 18.90 22.17 20.24 profit per common share — diluted 18.81 22.05 20.12 weighted-average common shares outstanding (millions) - basic 470.0 486.7 510.6 - diluted 472.3 489.4 513.6 profit attributable to common shareholders. diluted by assumed exercise of stock-based compensation awards using the treasury stock method. see accompanying notes to consolidated financial statements. statement 2 caterpillar inc. consolidated comprehensive income (loss) for the years ended december 31 (millions of dollars) profit (loss) of consolidated and affiliated companies 8882 10788 10332 other comprehensive income (loss) net of tax (note 17): foreign currency translation: pension and other postretirement benefits: derivative financial instruments: available-for-sale securities: total other comprehensive income (loss) net of tax comprehensive income (loss) 9581 10137 10969 less: comprehensive income (loss) attributable to the noncontrolling interests comprehensive income (loss) attributable to shareholders 9583 10141 10972 see accompanying notes to consolidated financial statements. statement 3 caterpillar inc. consolidated financial position at december 31 (dollars in millions) assets current assets: cash and cash equivalents 9980 6889 receivables – trade and other 10920 9282 receivables – finance 10649 9565 prepaid expenses and other current assets 2801 3119 inventories 18135 16827 total current assets 52485 45682 property plant and equipment – net 15140 13361 long-term receivables – trade and other 2142 1225 long-term receivables – finance 14272 13242 noncurrent deferred and refundable income taxes 2882 3312 intangible assets goodwill 5321 5241 other assets 6102 5302 total assets 98585 87764 liabilities current liabilities: short-term borrowings: financial products 5514 4393 accounts payable 8968 7675 accrued expenses 5587 5243


Property, plant and equipment – net
15,140
13,361
Long-term receivables – trade and other
2,142
1,225
Long-term receivables – finance
14,272
13,242
Noncurrent deferred and refundable income taxes
2,882
3,312
Intangible assets
Goodwill
5,321
5,241
Other assets
6,102
5,302
Total assets
98,585
87,764
Liabilities
Current liabilities:
Short-term borrowings:
Financial Products
5,514
4,393
Accounts payable
8,968
7,675
Accrued expenses
5,587
5,243
Accrued wages, salaries and employee benefits
2,554
2,391
Customer advances
3,314
2,322
Dividends payable
Other current liabilities
2,798
2,909
Long-term debt due within one year:
Machinery, Power & Energy
Financial Products
7,085
6,619
Total current liabilities
36,558
32,272
Long-term debt due after one year:
Machinery, Power & Energy
10,678
8,564
Financial Products
20,018
18,787
Liability for postemployment benefits
3,838
3,757
Other liabilities
6,175
4,890
Total liabilities
77,267
68,270
Commitments and contingencies (Notes 21 and 22)
Shareholders’ equity
Common stock of $
1.00
par value:
Authorized shares:
2,000,000,000
Issued shares: (2025 and 2024 –
814,894,624
shares) at paid-in amount
7,181
6,941
Treasury stock: (2025 -
349,607,292
shares; and 2024 -
336,962,600
shares) at cost
49,539
44,331
Profit employed in the business
65,448
59,352
Accumulated other comprehensive income (loss)
1,772
2,471
Noncontrolling interests
Total shareholders’ equity
21,318
19,494
Total liabilities and shareholders’ equity
98,585
87,764
See accompanying notes to Consolidated Financial Statements.
STATEMENT 4
Caterpillar Inc.
Changes in Consolidated Shareholders’ Equity for the Years Ended December 31
(Dollars in millions)
Common
stock
Treasury
stock
Profit
employed
in the
business
Accumulated
other
comprehensive
income (loss)
Noncontrolling
interests
Total
Balance at December 31, 2022
6,560
31,748
43,514
2,457
15,891
Profit (loss) of consolidated and affiliated companies
10,335
10,332
Foreign currency translation, net of tax
Pension and other postretirement benefits, net of tax
Derivative financial instruments, net of tax
Available-for-sale securities, net of tax
Change in ownership from noncontrolling interests
Dividends declared
2,599
Common shares issued from treasury stock for stock-based compensation:
2,497,799
Stock-based compensation expense
Common shares repurchased:
19,466,020
4,675
Outstanding authorized accelerated share repurchase
Other
Balance at December 31, 2023
6,403
36,339
51,250
1,820
19,503
Profit (loss) of consolidated and affiliated companies
10,792
10,788
Foreign currency translation, net of tax
Pension and other postretirement benefits, net of tax
Derivative financial instruments, net of tax
Available-for-sale securities, net of tax
Dividends declared
2,690
Common shares issued from treasury stock for stock-based compensation:
1,972,037
Stock-based compensation expense
Common shares repurchased:
23,417,282
7,997
Settlement of outstanding authorized accelerated share repurchase
Other
Balance at December 31, 2024

Question: What was Caterpillar Inc.'s total assets in fiscal year 2025?

what was caterpillar inc.'s total assets in fiscal year 2025?

property plant and equipment – net 15140 13361 long-term receivables – trade and other 2142 1225 long-term receivables – finance 14272 13242 noncurrent deferred and refundable income taxes 2882 3312 intangible assets goodwill 5321 5241 other assets 6102 5302 total assets 98585 87764 liabilities current liabilities: short-term borrowings: financial products 5514 4393 accounts payable 8968 7675 accrued expenses 5587 5243 accrued wages salaries and employee benefits 2554 2391 customer advances 3314 2322 dividends payable other current liabilities 2798 2909 long-term debt due within one year: machinery power & energy financial products 7085 6619 total current liabilities 36558 32272 long-term debt due after one year: machinery power & energy 10678 8564 financial products 20018 18787 liability for postemployment benefits 3838 3757 other liabilities 6175 4890 total liabilities 77267 68270 commitments and contingencies (notes 21 and 22) shareholders' equity common stock of 1.00 par value: authorized shares: 2000000000 issued shares: (2025 and 2024 – 814894624 shares) at paid-in amount 7181 6941 treasury stock: (2025 - 349607292 shares; and 2024 - 336962600 shares) at cost 49539 44331 profit employed in the business 65448 59352 accumulated other comprehensive income (loss) 1772 2471 noncontrolling interests total shareholders' equity 21318 19494 total liabilities and shareholders' equity 98585 87764 see accompanying notes to consolidated financial statements. statement 4 caterpillar inc. changes in consolidated shareholders' equity for the years ended december 31 (dollars in millions) common stock treasury stock profit employed in the business accumulated other comprehensive income (loss) noncontrolling interests total balance at december 31 2022 6560 31748 43514 2457 15891 profit (loss) of consolidated and affiliated companies 10335 10332 foreign currency translation net of tax pension and other postretirement benefits net of tax derivative financial instruments net of tax available-for-sale securities net of tax change in ownership from noncontrolling interests dividends declared 2599 common shares issued from treasury stock for stock-based compensation: 2497799 stock-based compensation expense common shares repurchased: 19466020 4675 outstanding authorized accelerated share repurchase other balance at december 31 2023 6403 36339 51250 1820 19503 profit (loss) of consolidated and affiliated companies 10792 10788 foreign currency translation net of tax pension and other postretirement benefits net of tax derivative financial instruments net of tax available-for-sale securities net of tax dividends declared 2690 common shares issued from treasury stock for stock-based compensation: 1972037 stock-based compensation expense common shares repurchased: 23417282 7997 settlement of outstanding authorized accelerated share repurchase other balance at december 31 2024


Question: What was Caterpillar Inc.'s gross margin in fiscal year 2025?

what was caterpillar inc.'s gross margin in fiscal year 2025?


Question: What was Caterpillar Inc.'s operating cash flow margin in fiscal year 2025?

what was caterpillar inc.'s operating cash flow margin in fiscal year 2025?


Question: By what percentage did Caterpillar Inc.'s operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did caterpillar inc.'s operating income change from fiscal year 2024 to fiscal year 2025?

by what percentage did operating income change from fiscal year 2024 to fiscal year 2025?


Question: By what percentage did Caterpillar Inc.'s revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did caterpillar inc.'s revenue change from fiscal year 2024 to fiscal year 2025?

by what percentage did revenue change from fiscal year 2024 to fiscal year 2025?


YEAR ENDED MAY 31,
(In millions, except per share data)
Revenues
46,309
51,362
51,217
Cost of sales
26,519
28,475
28,925
Gross profit
19,790
22,887
22,292
Demand creation expense
4,689
4,285
4,060
Operating overhead expense
11,399
12,291
12,317
Total selling and administrative expense
16,088
16,576
16,377
Interest expense (income), net
Other (income) expense, net
Income before income taxes
3,885
6,700
6,201
Income tax expense
1,000
1,131
NET INCOME
3,219
5,700
5,070
Earnings per common share:
Basic
2.17
3.76
3.27
Diluted
2.16
3.73
3.23
Weighted average common shares outstanding:
Basic
1,484.9
1,517.6
1,551.6
Diluted
1,487.6
1,529.7
1,569.8
The accompanying Notes to the Consolidated Financial Statements are an integral part of this statement.
2025 FORM 10-K
NIKE, INC.

Question: What was NIKE, Inc.'s net income in fiscal year 2025?

what was net income in fiscal year 2025?

what was nike inc.'s net income in fiscal year 2025?

year ended may 31 (in millions except per share data) revenues 46309 51362 51217 cost of sales 26519 28475 28925 gross profit 19790 22887 22292 demand creation expense 4689 4285 4060 operating overhead expense 11399 12291 12317 total selling and administrative expense 16088 16576 16377 interest expense (income) net other (income) expense net income before income taxes 3885 6700 6201 income tax expense 1000 1131 net income 3219 5700 5070 earnings per common share: basic 2.17 3.76 3.27 diluted 2.16 3.73 3.23 weighted average common shares outstanding: basic 1484.9 1517.6 1551.6 diluted 1487.6 1529.7 1569.8 the accompanying notes to the consolidated financial statements are an integral part of this statement. 2025 form 10-k nike inc.


YEAR ENDED MAY 31,
(Dollars in millions)
Cash provided (used) by operations:
Net income
3,219
5,700
5,070
Adjustments to reconcile net income to net cash provided (used) by operations:
Depreciation and amortization
Deferred income taxes
Stock-based compensation
Impairment and other
Net foreign currency adjustments
Changes in certain working capital components and other assets and liabilities:
(Increase) decrease in accounts receivable
(Increase) decrease in inventories
(Increase) decrease in prepaid expenses, operating lease right-of-use assets and other current and non-current assets
Increase (decrease) in accounts payable, accrued liabilities, operating lease liabilities and other current and non-current liabilities
Cash provided (used) by operations
3,698
7,429
5,841
Cash provided (used) by investing activities:
Purchases of short-term investments
3,234
4,767
6,059
Maturities of short-term investments
2,269
3,356
Sales of short-term investments
3,062
4,219
4,184
Additions to property, plant and equipment
Other investing activities
Cash provided (used) by investing activities
Cash provided (used) by financing activities:
Increase (decrease) in notes payable, net
Repayment of borrowings
1,000
Proceeds from exercise of stock options and other stock issuances
Repurchase of common stock
2,985
4,250
5,480
Dividends — common and preferred
2,300
2,169
2,012
Other financing activities
Cash provided (used) by financing activities
5,820
5,888
7,447
Effect of exchange rate changes on cash and equivalents
Net increase (decrease) in cash and equivalents
2,396
2,419
1,133
Cash and equivalents, beginning of year
9,860
7,441
8,574
CASH AND EQUIVALENTS, END OF YEAR
7,464
9,860
7,441
Supplemental disclosure of cash flow information:
Cash paid during the year for:
Interest, net of capitalized interest
Income taxes
1,226
1,299
1,517
Non-cash additions to property, plant and equipment
Dividends declared and not paid
The accompanying Notes to the Consolidated Financial Statements are an integral part of this statement.
2025 FORM 10-K
NIKE, INC.

Question: What was NIKE, Inc.'s operating cash flow in fiscal year 2025?

net cash provided by used in operating activities

what was nike inc.'s operating cash flow in fiscal year 2025?

what was operating cash flow in fiscal year 2025?

year ended may 31 (dollars in millions) cash provided (used) by operations: net income 3219 5700 5070 adjustments to reconcile net income to net cash provided (used) by operations: depreciation and amortization deferred income taxes stock-based compensation impairment and other net foreign currency adjustments changes in certain working capital components and other assets and liabilities: (increase) decrease in accounts receivable (increase) decrease in inventories (increase) decrease in prepaid expenses operating lease right-of-use assets and other current and non-current assets increase (decrease) in accounts payable accrued liabilities operating lease liabilities and other current and non-current liabilities cash provided (used) by operations 3698 7429 5841 cash provided (used) by investing activities: purchases of short-term investments 3234 4767 6059 maturities of short-term investments 2269 3356 sales of short-term investments 3062 4219 4184 additions to property plant and equipment other investing activities cash provided (used) by investing activities cash provided (used) by financing activities: increase (decrease) in notes payable net repayment of borrowings 1000 proceeds from exercise of stock options and other stock issuances repurchase of common stock 2985 4250 5480 dividends — common and preferred 2300 2169 2012 other financing activities cash provided (used) by financing activities 5820 5888 7447 effect of exchange rate changes on cash and equivalents net increase (decrease) in cash and equivalents 2396 2419 1133 cash and equivalents beginning of year 9860 7441 8574 cash and equivalents end of year 7464 9860 7441 supplemental disclosure of cash flow information: cash paid during the year for: interest net of capitalized interest income taxes 1226 1299 1517 non-cash additions to property plant and equipment dividends declared and not paid the accompanying notes to the consolidated financial statements are an integral part of this statement. 2025 form 10-k nike inc.


Question: What was NIKE, Inc.'s revenue in fiscal year 2025?

revenue from contract with customer excluding assessed tax

what was nike inc.'s revenue in fiscal year 2025?